Does Metformin Treatment During Pregnancy Modify the Future Metabolic Profile in Women With PCOS? | Zendy

Maria Othelie Underdal | Zendy; Solhild Stridsklev | Zendy; Ingrid Hennum Oppen | Zendy; Kristin Høgetveit | Zendy; Marianne Andersen | Zendy; Eszter Vanky | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Does Metformin Treatment During Pregnancy Modify the Future Metabolic Profile in Women With PCOS?

Author(s) -

Maria Othelie Underdal,

Solhild Stridsklev,

Ingrid Hennum Oppen,

Kristin Høgetveit,

Marianne Andersen,

Eszter Vanky

Publication year - 2018

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2018-00485

Subject(s) - metformin , medicine , polycystic ovary , pregnancy , body mass index , placebo , bioelectrical impedance analysis , endocrinology , waist–hip ratio , insulin , waist , obstetrics , insulin resistance , alternative medicine , pathology , biology , genetics

Worldwide, metformin is prescribed to improve pregnancy outcome in polycystic ovary syndrome (PCOS). Metformin may also benefit future health by modulating increased metabolic stress during pregnancy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research